Alfred D. Kingsley, Director at Asterias Biotherapeutics, Inc. (AST), bought 5,000 shares at $4.32 ($22K) on 2015-06-25, disclosed to the SEC on 2015-06-26.
Open-market purchase of $22k AST by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OCX | BUY | 2022-08-17 | $5K | — | Filing → |
| OCX | SELL | 2020-12-28 | $2K | — | Filing → |
| OCX | SELL | 2020-12-23 | $13K | — | Filing → |